Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription 06.02.2012 2 Arch Neurol 2 Clin Ther 6 J Neuroimmunol 1 J Neurol 1 J Neurol Neurosurg Psychiatry 1 J Neurol Sci 6 Mult Scler 1 Neurology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Arch Neurol

1. WILLIAMS MA , Venkatesan A
   No endovascular innovation without evaluation in chronic cerebrospinal venous insufficiency: a call for the IDEAL model.
   Arch Neurol. 2011;68:1510-2.
   PubMed     Text format     Related articles   
   
   
   
2. VAKNIN-DEMBINSKY A , Abramsky O, Petrou P, Ben-Hur T, et al
   Myasthenia Gravis-Associated Neuromyelitis Optica-Like Disease: An Immunological Link Between the Central Nervous System and Muscle?
   Arch Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Clin Ther

3. EVANS C , Tam J, Kingwell E, Oger J, et al
   Long-Term Persistence With the Immunomodulatory Drugs for Multiple Sclerosis: A Retrospective Database Study.
   Clin Ther. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. QIZILBASH N , Mendez I, Sanchez-de la Rosa R
   Benefit-risk analysis of glatiramer acetate for relapsing-remitting and clinically isolated syndrome multiple sclerosis.
   Clin Ther. 2012;34:159-176.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   J Neuroimmunol

5. KALISZEWSKA A , De Jager PL
   Exploring the role of the epigenome in multiple sclerosis: A window onto cell-specific transcriptional potential.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. VILLOSLADA P , Baranzini S
   Data integration and systems biology approaches for biomarker discovery: Challenges and opportunities for multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. ZHONG X , Wang H, Dai Y, Wu A, et al
   Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
   J Neuroimmunol. 2011;240-241:104-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. LAUGEL B , Borlat F, Galibert L, Vicari A, et al
   Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
   J Neuroimmunol. 2011;240-241:52-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. PEELEN E , Damoiseaux J, Smolders J, Knippenberg S, et al
   Th17 expansion in MS patients is counterbalanced by an expanded CD39(+) regulatory T cell population during remission but not during relapse.
   J Neuroimmunol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. DOBSON R , Meier UC, Giovannoni G
    More to come: humoral immune responses in MS.
    J Neuroimmunol. 2011;240-241:13-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Neurol

11. FERNANDEZ O , Oreja-Guevara C, Arroyo R, Izquierdo G, et al
    Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study.
    J Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Neurol Neurosurg Psychiatry

12. KELLY SB , Chaila E, Kinsella K, Duggan M, et al
    Using atypical symptoms and red flags to identify non-demyelinating disease.
    J Neurol Neurosurg Psychiatry. 2012;83:44-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Neurol Sci

13. GRANT WB , Mascitelli L
    Evidence that the north-south gradient of multiple sclerosis may not have disappeared.
    J Neurol Sci. 2012.
    PubMed     Text format     Related articles   
    
    
    

    
    Mult Scler

14. FROMONT A , Binquet C, Sauleau E, Fournel I, et al
    National estimate of multiple sclerosis incidence in France (2001-2007).
    Mult Scler. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. GAFSON AR , Giovannoni G
    Towards the incorporation of lumbar puncture into clinical trials for multiple sclerosis.
    Mult Scler. 2012.
    PubMed     Text format     Related articles   
    
    
    
16. VILLOSLADA P , Cuneo A, Gelfand J, Hauser SL, et al
    Color vision is strongly associated with retinal thinning in multiple sclerosis.
    Mult Scler. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. SIMON KC , O'Reilly EJ, Munger KL, Finerty S, et al
    Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
    Mult Scler. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. TILL C , Udler E, Ghassemi R, Narayanan S, et al
    Factors associated with emotional and behavioral outcomes in adolescents with multiple sclerosis.
    Mult Scler. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. GAVASSO S , Gjertsen B, Anderssen E, Myhr K, et al
    Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis.
    Mult Scler. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Neurology

20. FOX RJ , Rudick RA
    Risk stratification and patient counseling for natalizumab in multiple sclerosis.
    Neurology. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: